EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Marine Compound Isaridin E Ameliorates Lipopolysaccharide-Induced Vascular Endothelial Inflammation via the Downregulation of the TLR4/NF-κB Signaling Pathway

Jing Liu, Xin Zeng, Yu-Quan Lin, Yu-Sheng Peng, Lan Liu iD, Sen-Hua Chen iD, Yan-Hua Du iD

Marine Drugs · 2025

DOI: 10.3390/md23040145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Jing Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Anti-Inflammatory Agents, Depsipeptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key R&D Program of Guangdong Province, China, Key-Area Research and Development Program of Guangdong Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Isaridin E, a cyclodepsipeptide derived from the marine fungus Beauveria felina (SYSU-MS7908), has been demonstrated to possess multiple biological properties. In this study, we employed both lipopolysaccharide (LPS)-stimulated human umbilical vein endothelial cells (HUVECs) and a LPS-induced murine endotoxemia model to investigate its anti-inflammatory effects. Our results revealed that isaridin E suppressed the expression of pro-inflammatory cytokines and adhesion molecules in a concentration dependent manner, while also reducing monocyte adhesion to endothelial cells. Furthermore, this compound attenuated vascular hyperpermeability and inflammatory cell infiltration in the lungs, as well as preserving the integrity of the aortic and pulmonary tissues. At the molecular level, isaridin E was found to downregulate TLR4 expression, increase IκBα levels, and inhibit the LPS-induced phosphorylation and nuclear translocation of NF-κB p65. In conclusion, our findings indicate that isaridin E exerts robust anti-inflammatory effects in LPS-induced endotoxemia through the suppression of the TLR4/NF-κB signaling axis, positioning it as a promising therapeutic candidate for vascular inflammatory disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4Anti-Inflammatory AgentsDepsipeptidesLipopolysaccharidesAnimalsHumansHuman Umbilical Vein Endothelial CellsSignal TransductionMiceNF-kappa BDown-RegulationEndotoxemiaMaleInflammationMice, Inbred C57BLCytokinesAquatic OrganismsEndothelium, VascularCell AdhesionFungal ProteinsPeptides, Cyclic

Stichwörter der Autor:innen

NF-κBTLR4endothelial inflammationisaridin Emarine natural products

Substanzen

LipopolysaccharidesToll-Like Receptor 4NF-kappa BAnti-Inflammatory AgentsDepsipeptidesTLR4 protein, humanCytokinesisaridin EFungal ProteinsPeptides, Cyclic

Autor:innen und Institutionen

  • Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
  • Department of Pharmacy, The Second Clinical Medical College, Southern Medical University, Guangzhou 510280, China.
  • School of Marine Sciences, Sun Yat-sen University, Guangzhou 510275, China.
  • Southern Marine Sciences and Engineering Guangdong Laboratory (Zhuhai), Zhuhai 519000, China.

ORCID-Profile: Lan Liu, Sen-Hua Chen, Yan-Hua Du

Förderung

  • National Natural Science Foundation of China
  • Key R&D Program of Guangdong Province, China
  • Key-Area Research and Development Program of Guangdong Province, China

Zitieren

APA

Liu, J., Zeng, X., Lin, Y. Q., Peng, Y. S., Liu, L., Chen, S. H., & Du, Y. H. (2025). The Marine Compound Isaridin E Ameliorates Lipopolysaccharide-Induced Vascular Endothelial Inflammation via the Downregulation of the TLR4/NF-κB Signaling Pathway. Marine Drugs. https://doi.org/10.3390/md23040145

Vancouver

Liu J, Zeng X, Lin YQ, Peng YS, Liu L, Chen SH, et al. The Marine Compound Isaridin E Ameliorates Lipopolysaccharide-Induced Vascular Endothelial Inflammation via the Downregulation of the TLR4/NF-κB Signaling Pathway. Marine Drugs. 2025. doi:10.3390/md23040145

BibTeX
@article{Liu2025,
  author = {Liu, Jing and Zeng, Xin and Lin, Yu-Quan and Peng, Yu-Sheng and Liu, Lan and Chen, Sen-Hua and Du, Yan-Hua},
  title = {The Marine Compound Isaridin E Ameliorates Lipopolysaccharide-Induced Vascular Endothelial Inflammation via the Downregulation of the TLR4/NF-κB Signaling Pathway},
  journal = {Marine Drugs},
  year = {2025},
  doi = {10.3390/md23040145}
}
Kostenlos starten →